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Edited by Giulio Superti-FurgaAbstract During gene transcription, RNA polymerase (Pol) II
encounters obstacles, including lesions in the DNA template.
Here, we review a recent structure–function analysis of Pol II
transcribing DNA with a bulky photo-lesion in the template
strand. The study provided the molecular basis for recognition
of a damaged DNA by Pol II, which is the ﬁrst step in transcrip-
tion-coupled DNA repair (TCR). The results have general impli-
cations for damage recognition and the TCR mechanism.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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transcription1. Structural studies of Pol II elongation
RNA polymerase (Pol) II synthesizes eukaryotic mRNA in
the course of gene transcription. To ensure processive mRNA
chain elongation, Pol II forms a stable elongation complex
(EC) with transcribed DNA and product RNA. The X-ray
structure of Pol II [1–5] enabled structural studies of Pol II-
nucleic acid complexes [6–11]. These studies elucidated many
aspects of the molecular mechanism for mRNA chain elonga-
tion, and suggested how Pol II unwinds DNA, how it separates
the RNA product from the DNA template, how it incorpo-
rates nucleoside triphosphate (NTP) substrates into the grow-
ing RNA chain, and how it can be inhibited by RNA (reviewed
in part in [12,13]).2. Overcoming a natural obstacle during transcription
Additional structural studies have elucidated how Pol II
deals with a natural obstacle to transcription, intrinsic DNA
arrest sites. At such sites, Pol II moves backwards along
DNA and RNA, resulting in extrusion of the growing RNA
3 0-end through the polymerase pore beneath the active site. Ar-
rested polymerase cannot continue elongation by itself, but
must be reactivated by mRNA cleavage. In such cases the very
weak intrinsic RNA nuclease activity of Pol II is strongly stim-*Corresponding author. Fax: +49 89 2180 76999.
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TFIIS inserts a hairpin into the polymerase pore and comple-
ments the active site with acidic residues, changes the enzyme
conformation, and repositions the RNA transcript [7,16,17].
These studies suggested a ‘‘tunability’’ of the Pol II active site,
which can apparently catalyze diﬀerent reactions, including
RNA synthesis and RNA cleavage. RNA cleavage creates a
new 3 0-end directly adjacent to the active site, from which tran-
scription can resume, and the obstacle can be overcome.3. Damage recognition and TCR
A recent study shows how Pol II deals with another obstacle,
a bulky photo-lesion in the DNA template strand [18] (Fig. 1).
The results not only elucidate an unexpected and complicated
mechanism of damage recognition by Pol II, they also have
implications for understanding how the damage is subse-
quently removed. Ultraviolet light damages DNA by inducing
dimerization of adjacent pyrimidines in a DNA strand. The
resulting cyclobutane pyrimidine dimer (CPD) lesions can
block transcription and replication, and are a major cause of
skin cancer [19]. Cells can eliminate CPDs slowly by gen-
ome-wide nucleotide excision repair (NER). For rapid and eﬃ-
cient repair, however, cells use a NER sub-pathway referred to
as transcription-coupled DNA repair (TCR). TCR speciﬁcally
removes lesions such as CPDs from the DNA strand tran-
scribed by Pol II [20]. It is thought that only those lesions trig-
ger TCR that can stably stall Pol II. CPDs are bulky lesions
that lead to Pol II stalling, but other types of damages, such
as oxidative damages, can be bypassed by Pol II, and would
escape TCR [21]. Pol II stalling apparently triggers TCR by
recruitment of a transcription-repair coupling factor (Rad26/
CSB in yeast/human), and factors required for subsequent
steps of nucleotide excision repair, including TFIIH, which un-
winds DNA, and endonucleases, which incise the DNA strand
on either side of the lesion [20,22–25]. The obtained DNA gap
is subsequently ﬁlled by DNA synthesis and ligation [26,27].4. A tool box for studying damage recognition
To study the mechanism of DNA damage recognition by Pol
II, expertise in the synthesis of lesion-containing DNA (group
of T. Carell at the University of Munich) was combined with
expertise in preparing functional crystallization-grade ECs ofblished by Elsevier B.V. All rights reserved.
Fig. 1. Simpliﬁed mechanism of CPD DNA damage recognition by Pol II. On the top, a schematic is shown that depicts the last few steps before Pol
II stalling. On the bottom, nucleic acids structures in Pol II ECs containing a thymine–thymine CPD lesion before (left) and in the active site (right)
are shown. DNA template, DNA non-template, and RNA strands are in blue, cyan, and red, respectively. The CPD is shown as a stick model in
orange. The active site magnesium ion (metal A) is depicted as a magenta sphere. Figures prepared with Pymol (www.pymol.org).
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introduced into the DNA template strand at several diﬀerent
positions around the polymerase active site and the resulting
Pol II ECs were studied structurally and in RNA elongation
assays. The highly reproducible and clean system for reconsti-
tuting deﬁned, fully functional Pol II ECs will be very useful
for a detailed structure–function analysis of many aspects of
the transcription mechanism in the future.5. The CPD lesion passes a barrier and enters the active site
Pol II stalls when a CPD in the DNA template strand
reaches the enzyme active site, after nucleotide incorporation
opposite both CPD thymines [18,28,29]. However, it is not
obvious how the CPD can reach the active site since transfer
of a DNA template base from the downstream position +2
to the nucleotide insertion site at +1 over the polymerase
bridge helix normally requires twisting of the base by 90,
and such twisting is not possible for the CPD thymines, since
they are covalently linked. Indeed, the CPD is not stably
accommodated at positions +1/+2, and has to pass a translo-
cation barrier to get into this position [18].6. The CPD induces misincorporation that stalls Pol II
A CPD can be stably accommodated at positions 1/+1 of
the template strand in the active site of Pol II. Whereas Pol
II correctly incorporates AMP opposite the 3 0-thymine of the
CPD, only UMP can be incorporated opposite the 5 0-thymine
[18,29]. The UMP misincorporation is very slow, and is therate-limiting step in reaching the stalled state [18]. Speciﬁc
UMP misincorporation may arise from the unusual location
of the CPD 5 0-thymine that adopts a wobble position with re-
spect to the base in the undamaged complex [18]. The wobbled
5 0-thymine could form two hydrogen bonds with UTP, but not
with other NTPs. Pol II stalls because translocation of the
CPD 5 0-thymine–uracile mismatch base pair from position
+1 to position 1 is strongly disfavored. This translocation
event would move the damage-containing mismatch into the
1 position of the DNA–RNA hybrid, resulting in a distortion
that likely destabilizes the EC [30]. Replacement of the misin-
corporated UMP by AMP in an artiﬁcial scaﬀold enables CPD
bypass [18]. Thus, Pol II stalling requires CPD-directed misin-
corporation, and distortions due to the CPD alone are insuﬃ-
cient to cause Pol II stalling. Indeed, a T–U mismatch base
pair alone was suﬃcient to stall the vast majority of Pol II
complexes [18]. In contrast, DNA polymerases can correctly
incorporate adenine opposite both CPD thymines, and, depen-
dent on the type of polymerase, this can lead to stalling or le-
sion bypass [31,32].7. A topological model for TCR
What is the cellular signal that indicates to the repair
machinery that a DNA lesion has been detected? In other
words, how does the damage-stalled EC trigger assembly of
the repair machinery? The lesion is deeply buried in the Pol
II active site, thus it cannot be recognized by another factor.
One possibility is that damaged DNA causes a conformational
change in the Pol II EC that triggers recruitment of repair fac-
tors in an allosteric manner. However, the polymerase confor-
Fig. 2. Topological model for transcription-coupled DNA repair. The lesion-containing Pol II EC is shown schematically. The view and color code
are as in Fig. 1. An orange star and a magenta sphere indicate the CPD lesion and the active site, respectively. The upstream DNA was placed on Pol
II on the basis of its location in the bacterial RNA polymerase–promoter complex [38]. The non-template strand in the bubble region was modeled.
TFIIH helicase subunits XPD and XPB may be involved in extending the transcription bubble in the upstream and downstream direction,
respectively, to enable dual incision. Modeling shows that incisions could occur at the two edges of an extended bubble around 10–15 nucleotides
upstream (3 0) and around 15–20 nucleotides downstream (5 0) of the lesion.
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does not exclude that allostery exists and was simply not ob-
served, but it argues against an allosteric model for TCR. In
addition, all observations are consistent with excision of a le-
sion-containing DNA fragment in the presence of Pol II. Such
a model for eukaryotic TCR combines and extends previous
models [24,33,34] and can explain recognition of the stalled
complex without allostery or exposure of the lesion (Fig. 2).
At a CPD lesion, CSB can counteract TFIIS-induced back-
tracking [35,36], resulting in a stably stalled complex. This
may open a time window for assembly of the repair machinery.
TFIIH may then catalyze extension of the transcription bub-
ble, permitting dual incision of the template strand on the
Pol II surface [23,24]. The lesion-containing DNA fragment
and the RNA transcript could then be removed together with
Pol II, although dual incision is apparently not suﬃcient to
achieve this [24]. The remaining gapped DNA is repaired.
Pol II may be recycled, circumventing its ubiquitination and
destruction [37].8. Conclusions and perspectives
The new study shows how a cellular RNA polymerase recog-
nizes a DNA photo-lesion, and explains why the polymerase
stalls when it encounters the lesion. The new data also suggest
a preferred model for TCR that can be tested experimentally.
In addition, the study predicts that DNA damages that have
the potential to direct misincorporation can generally stallPol II and trigger TCR. However, given the unexpectedly com-
plicated mechanism of CPD recognition by Pol II, recognition
of diﬀerent types of lesions must be studied in a detailed man-
ner both structurally and functionally before general conclu-
sions can be drawn. Finally, there are many open questions
on TCR events subsequent to damage recognition, and it will
require a highly interdisciplinary approach to address these
experimentally.References
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